Electriq Power Holdings, Inc.
ELIQ News Today: Stay Updated with the Latest Electriq Power Holdings, Inc. News in Real Time
Find ELIQ news now at Meyka AI. Stay informed with the latest Electriq Power Holdings, Inc. stocks updates, including price news, market analysis, and expert insights.
March 17: Cuba Blackout Deepens Oil Sanctions Risk for Energy Markets
Cuba blackout raises oil sanctions risk. What it means for Australian fuel prices and ASX energy exposure. We map flows, scenarios, and investor actions to watch today.
William Blair Maintains Outperform on Bumble Inc. (BMBL) March 16, 2026
BMBL analyst rating: William Blair and Deutsche Bank maintained ratings on March 16, 2026; implications and Meyka grade B
JMT.LS Jerónimo Martins (EURONEXT) pre-market: results Mar 2026, margins key
Pre-market earnings preview for JMT.LS stock: Jerónimo Martins reports Mar 18, 2026; EPS, margins and Meyka forecast +4.26% upside.
Gemini AI March 17: Meta mulls Google tie-up after Avocado delay
Gemini AI leads as Meta delays Avocado by two months. What Google Gemini licensing could mean for HK advertisers, app developers, and investors tracking Big Tech AI strategies.
Germany Special Fund March 17: 10% Investment Quota on Track, H2 Boost
Germany special fund set to activate as Berlin targets a 10% core-budget investment quota by 2026, with first impacts expected in H2 2026. What it means for infrastructure spending Germany, data hubs,
H.C. Wainwright Maintains Buy on Savara Inc. (SVRA) March 2026
H.C. Wainwright maintains Buy on Savara Inc.; SVRA analyst rating held ahead of August PDUFA
1827.HK Miricor (HKSE) +34.29% pre-market HK$0.94 17 Mar 2026: watch volume
Pre-market high-volume move in 1827.HK stock to HK$0.94 on 17 Mar 2026; volume spike may signal short-term momentum
AirSculpt (AIRS) NASDAQ +51% after 12b-25 filing 16 Mar 2026: earnings Mar 20
AIRS stock jumps after AirSculpt files 12b-25; we preview Mar 20 earnings and Meyka AI outlook
Leerink Maintains Outperform on Spyre Therapeutics, Inc. (SYRE) March 16, 2026
Leerink maintains Outperform on Spyre; SYRE analyst rating stays positive on March 16, 2026